Cargando…

Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?

Ovarian adrenal rest tumors (OARTs) are very rare. We describe a case of a young woman with uncontrolled classical congenital adrenal hyperplasia (CCAH), presenting with bilateral OARTs, successfully treated with steroid replacement. A 20-year-old woman, known to have 21OH-CCAH, presented with sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Koren, Ronit, Koren, Shlomit, Khashper, Alla, Benbassat, Carlos, Pekar-Zlotin, Marina, Vaknin, Zvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065401/
https://www.ncbi.nlm.nih.gov/pubmed/34762785
http://dx.doi.org/10.20945/2359-3997000000415
_version_ 1785018101265334272
author Koren, Ronit
Koren, Shlomit
Khashper, Alla
Benbassat, Carlos
Pekar-Zlotin, Marina
Vaknin, Zvi
author_facet Koren, Ronit
Koren, Shlomit
Khashper, Alla
Benbassat, Carlos
Pekar-Zlotin, Marina
Vaknin, Zvi
author_sort Koren, Ronit
collection PubMed
description Ovarian adrenal rest tumors (OARTs) are very rare. We describe a case of a young woman with uncontrolled classical congenital adrenal hyperplasia (CCAH), presenting with bilateral OARTs, successfully treated with steroid replacement. A 20-year-old woman, known to have 21OH-CCAH, presented with severe abdominal pain, vomiting, diarrhea, and fever. As a result of poor compliance, 6 months before her admission hirsutism worsened and amenorrhea, hyperpigmentation, and weakness developed. ACTH levels were 278 < pmol/L and 17OHP 91.3 nmol/L. She was admitted for parenteral antibiotics and high-dose hydrocortisone treatment. CT revealed bilateral juxta-ovarian masses (6.2 x 3.6 x 7.4 cm left and 5 x 2.2 x 3.2 cm right) that on MRI were iso-intense in T1 and hypointense in T2, with early enhancement and rapid washout. One week of high-dose hydrocortisone resulted in significant clinical and laboratory improvement and the patient was discharged with 2 mg dexamethasone/day. One month later US revealed shrinkage of the masses and dexamethasone dose was decreased. At three months from discharge, she has resumed regular menses, and a repeated MRI revealed the para-ovarian masses have shrunk. One year after the diagnosis, the para-ovarian masses have shrunk more to 2.8 x 1.9 x 4.3 on the left and 2.1 x 0.9 x 1.2 on the right with less contrast enhancement in comparison to previous test possibly due to fibrotic changes of the tissue. OARTs are rare tumors with a poorly known natural history, and surgery has been the first option in the few reported cases. We demonstrate that medical treatment is a good alternative, leading to significant tumor shrinkage over a short period.
format Online
Article
Text
id pubmed-10065401
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Endocrinologia e Metabologia
record_format MEDLINE/PubMed
spelling pubmed-100654012023-04-01 Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? Koren, Ronit Koren, Shlomit Khashper, Alla Benbassat, Carlos Pekar-Zlotin, Marina Vaknin, Zvi Arch Endocrinol Metab Case Report Ovarian adrenal rest tumors (OARTs) are very rare. We describe a case of a young woman with uncontrolled classical congenital adrenal hyperplasia (CCAH), presenting with bilateral OARTs, successfully treated with steroid replacement. A 20-year-old woman, known to have 21OH-CCAH, presented with severe abdominal pain, vomiting, diarrhea, and fever. As a result of poor compliance, 6 months before her admission hirsutism worsened and amenorrhea, hyperpigmentation, and weakness developed. ACTH levels were 278 < pmol/L and 17OHP 91.3 nmol/L. She was admitted for parenteral antibiotics and high-dose hydrocortisone treatment. CT revealed bilateral juxta-ovarian masses (6.2 x 3.6 x 7.4 cm left and 5 x 2.2 x 3.2 cm right) that on MRI were iso-intense in T1 and hypointense in T2, with early enhancement and rapid washout. One week of high-dose hydrocortisone resulted in significant clinical and laboratory improvement and the patient was discharged with 2 mg dexamethasone/day. One month later US revealed shrinkage of the masses and dexamethasone dose was decreased. At three months from discharge, she has resumed regular menses, and a repeated MRI revealed the para-ovarian masses have shrunk. One year after the diagnosis, the para-ovarian masses have shrunk more to 2.8 x 1.9 x 4.3 on the left and 2.1 x 0.9 x 1.2 on the right with less contrast enhancement in comparison to previous test possibly due to fibrotic changes of the tissue. OARTs are rare tumors with a poorly known natural history, and surgery has been the first option in the few reported cases. We demonstrate that medical treatment is a good alternative, leading to significant tumor shrinkage over a short period. Sociedade Brasileira de Endocrinologia e Metabologia 2021-11-11 /pmc/articles/PMC10065401/ /pubmed/34762785 http://dx.doi.org/10.20945/2359-3997000000415 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Koren, Ronit
Koren, Shlomit
Khashper, Alla
Benbassat, Carlos
Pekar-Zlotin, Marina
Vaknin, Zvi
Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
title Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
title_full Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
title_fullStr Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
title_full_unstemmed Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
title_short Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
title_sort ovarian adrenal rest tumor in congenital adrenal hyperplasia: is medical treatment the first line option?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065401/
https://www.ncbi.nlm.nih.gov/pubmed/34762785
http://dx.doi.org/10.20945/2359-3997000000415
work_keys_str_mv AT korenronit ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption
AT korenshlomit ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption
AT khashperalla ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption
AT benbassatcarlos ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption
AT pekarzlotinmarina ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption
AT vakninzvi ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption